Deallus is a unique strategic intelligence consultancy operating across the global life sciences sector
Our mission is simple: to prepare you for the future by delivering the forward-thinking assurance you need in an uncertain and highly competitive world. The knowledge and clarity we provide helps life sciences companies shape future markets by making the right strategic decisions with confidence.
Episode 1: Navigating Market Disruption After COVID-19
Peter Hempshall, CEO of Deallus, is partnering with Rita Numerof, Founder & President of Numerof & Associates, for a discussion series centered on the lasting impact that COVID-19 will have on business models in the healthcare industry. Tune in to be part of a discussion on how the pandemic has accelerated key market shifts, how organizations will need to operate differently, and what solutions can be offered for successfully moving businesses forward in this new reality.
COVID-19 – tracking the fast-moving landscape
As the COVID-19 pandemic continues to impact patients, healthcare systems, and global economic outlooks, we focus on the key considerations and strategies for pharma companies when the data generation for possible therapies is becoming increasingly complex to analyze. There are several COVID-19 treatment and vaccine databases containing an aggregation of publicly-available information from validated sources detailing treatments and vaccines currently in development.
COVID-19, China, and Telemedicine
As COVID-19 continues to disrupt normalcy across the globe, China is responding with innovation in online health delivery and telemedicine. How has China encouraged telemedicine uptake? What are the factors contributing to China’s relatively quick utilization of telemedicine in the face of COVID-19? And what learnings can we gain from taking a closer look? We explore these questions in our latest addition to our COVID-19+Pharma Series.
Launch and COVID-19: Pharma’s Dilemma
COVID-19 is throwing a wrench in years’ worth of launch planning, introducing complications and delays into the regulatory process and severely constricting promotional and educational opportunities for new products. How is the pharmaceutical industry responding to these changes in well-laid plans? How are regulatory bodies responding? We consider the potential impact of the pandemic on launch timing and strategy here.
Our strategic intelligence services
We are a company of experienced and dedicated life sciences specialists. Our unparalleled competitive intelligence capabilities are enhanced by the strategic mindset that drives our entire organisation.
This enables us to provide you with the assured guidance you need to make the right strategic decisions. We are well equipped to assist with any issue at any stage of your product’s lifecycle.
Therapeutic Area Strategy Development
-
Clinical pathway design
-
Trial design
-
BD&L/Partnering Strategy
-
Portfolio prioritization
Brand Strategy Development
-
Forecasting
-
Stakeholder selection & engagement
-
Market Research
-
Message development
-
Patient journey
Brand Planning
-
Strategic/tactical plan development
-
Forecasting
-
Budgeting & tactics
-
Customer segmentation
-
Brand planning process support/PMO
Brand Positioning
-
Brand attribute testing
-
Differentiation
-
Positioning research
-
Training plan
Product Launch
-
Launch plan development
-
Launch office set-up & day-to-day operation
-
Launch readiness assessment
-
Progress reviews & tracking
Benchmarking
-
Analogue analysis
-
Best practices
-
Key performance drivers
-
Competitive capabilities
Pricing & Reimbursement
-
Payer landscape assessment
-
Pricing strategy
-
Patient support
-
Contracting strategy
-
Payer segmentation
Competitive Deep Dives
Competitive profiling of multiple potential sources of competitive advantage
-
TPP
-
Commercial capabilities
-
Regulatory/government affairs set-up
-
Pricing reimbursement approach
-
Value-added services
-
Field stakeholder engagement
Commercial Competitive Analysis
Studies on competitors:
-
Sales teams
-
Account teams
-
Commercial digital approach
-
Product positioning/messaging
Competitor Threat Analysis
Detailing competitor:
-
Strengths & weaknesses
-
Decision-making timelines
-
Commitments
-
Strategic intent
Workshops
-
Alignment workshops
-
Discovery workshops
-
Competitive insights workshops
Conference Coverage
-
In-depth coverage of presentations & booth displays
-
Expert commentary at industry conferences worldwide
Scenario Planning & War Gaming
-
Role plays
-
Simulations
-
What-if/contingency planning
-
Communications roadmap building
C.I. Best Practice Advisory
-
Boot camps
-
Masterclasses
-
Organization design for world-class C.I. functions
Deallus will give you the competitive edge you need
Everything we do provides confidence and certainty to enable you to make the right strategic decisions to outmanoeuvre the competition.
Class-leading reputation and heritage
Extensive therapy area expertise
Global reach with local expertise – 25+ languages spoken
Proven systematic approach to information gathering
The high quality of our analysis and the insights we reveal
The depth of knowledge and clarity we generate
Deallus will give you the competitive edge you need
Everything we do provides confidence and certainty to enable you to make the right strategic decisions to outmanoeuvre the competition.
Class-leading reputation and heritage
Extensive therapy area expertise
Global reach with local expertise – 25+ languages spoken
Proven systematic approach to information gathering
The high quality of our analysis and the insights we reveal
The depth of knowledge and clarity we generate
“If you are looking for an innovative life science consultancy that is a one stop shop, look no further than Deallus. We have worked with them on a range of projects over the past few years and they never disappoint. Whether we need help with new product planning, brand strategy or launch support, we can rely on Deallus to deliver compelling insights, robust consultancy and exceptional strategic guidance.”
Marketing Director, Top 10 pharma brand